Medacta Group SA Reports 16.2% Revenue Growth in 2024

Medacta Group SA announced an impressive 16.2% revenue growth in constant currency for the fiscal year 2024, reaching Euro 590.6 million. This increase reflects significant performance across all geographic markets and business lines, particularly in Knee and Extremities. The company also marked its 25th anniversary with an expanded focus on medical education, creating 177 new jobs to support its growth.

The growth was notably driven by EMEA and North America, each with 16.5% growth in constant currency, while Latin America saw a 22.5% increase. Asia Pacific also posted a growth of 14.5%. The Knee segment experienced an outstanding rise of 21.9%, and Extremities surged by 38.8%, fueled by advanced technologies and surgeon-specific innovations.

Medacta's achievements in 2024 were supported by continuous innovation, enhanced medical education programs, and strategic supply chain optimization aimed at better addressing customer needs and market opportunities.